Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study

NCT06335407 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Alcohol Use Disorder (AUD)
Post Traumatic Stress Disorder (PTSD)

Interventions

DRUG: Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 40µg
DRUG: Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 80µg

Sponsor

Pharmacotherapies for Alcohol and Substance Use Disorders Alliance

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]